PYXIS ONCOLOGY INC PYXS
COMMON STOCK · Common Stock · CUSIP 747324101
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersBoston, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 32.8m as of 2022-03-29, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $2.38.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2021 | 52 |
| Q1 2022 | 46 |
| Q2 2022 | 40 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2022 | 18 | 24 |
| Q2 2022 | 19 | 31 |
Biggest buyers
| Laurion Capital Management LP | Added | +2.0m |
| TANG CAPITAL MANAGEMENT LLC | New | +1.4m |
| CREDIT SUISSE AG/ | New | +965.5k |
| Newtyn Management, LLC | New | +800.0k |
| ACUTA CAPITAL PARTNERS, LLC | Added | +445.1k |
| VANGUARD GROUP INC | Added | +322.8k |
| MILLENNIUM MANAGEMENT LLC | New | +142.8k |
| MORGAN STANLEY | Added | +133.7k |
| CITIGROUP INC | Added | +79.3k |
| BVF INC/IL | Added | +77.0k |
Biggest sellers
| RTW INVESTMENTS, LP | Reduced | -1.4m |
| JANUS HENDERSON GROUP PLC | Sold out | -1.4m |
| RA CAPITAL MANAGEMENT, L.P. | Reduced | -1.3m |
| BlackRock Inc. | Reduced | -315.6k |
| HealthCor Management, L.P. | Sold out | -217.5k |
| ORBIMED ADVISORS LLC | Sold out | -143.6k |
| STATE STREET CORP | Reduced | -113.8k |
| PURA VIDA INVESTMENTS, LLC | Sold out | -113.4k |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | -84.7k |
| Ghost Tree Capital, LLC | Sold out | -75.0k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| GordonMD Global Investments LP 13G · passive investor -1.1 pts · filed 2026-10-09 | 16.4% |
Sullivan Lara
13D · may seek influence
+0.9 pts · filed 2025-04-02
Stated purposeItem 4 of the Schedule 13D is hereby amended and supplemented as follows: The response to Item 3 of this Amendment No. 5 is incorporated by reference herein. Full filing |
11.2% |
| BIOTECHNOLOGY VALUE FUND L P 13G · passive investor new · filed 2026-07-10 | 10.0% |
| Laurion Capital Management LP 13G · institution filed 2026-02-09 | 7.7% |
| Coastlands Capital LP 13G · institution new · filed 2026-10-05 | 5.4% |
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 0 | — | 0 | — | — |
| Q4 2021 | 4 | $12.5m | 0 | — | — |
| Q1 2022 | 0 | — | 0 | — | — |
| Q2 2022 | 0 | — | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2022-04-21 | Chin Mark Former Director · See footnote | Sold | $5.3m1.7m shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Laurion Capital Management LP 0.32% of their portfolio | 3.2m $7.5m | Added +2.0m |
| BVF INC/IL 0.34% of their portfolio | 2.9m $7.0m | Added +77.0k |
| PERCEPTIVE ADVISORS LLC 0.11% of their portfolio | 1.5m $3.6m | Unchanged |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 1.5m $3.6m | Reduced -1.6k |
| TANG CAPITAL MANAGEMENT LLC 0.50% of their portfolio | 1.4m $3.3m | New |
| CREDIT SUISSE AG/ 0.00% of their portfolio | 965.5k $2.3m | New |
| RA CAPITAL MANAGEMENT, L.P. 0.06% of their portfolio | 953.4k $2.3m | Reduced -1.3m |
| BARCLAYS PLC 0.00% of their portfolio | 947.7k $2.3m | Reduced -1.7k |
| VANGUARD GROUP INC 0.00% of their portfolio | 849.1k $2.0m | Added +322.8k |
| Newtyn Management, LLC 0.36% of their portfolio | 800.0k $1.9m | New |
| HHLR ADVISORS, LTD. 0.04% of their portfolio | 764.4k $1.8m | Unchanged |
| Tekla Capital Management LLC 0.07% of their portfolio | 708.3k $1.7m | Unchanged |
| RTW INVESTMENTS, LP 0.04% of their portfolio | 682.2k $1.6m | Reduced -1.4m |
| Cormorant Asset Management, LP 0.12% of their portfolio | 668.9k $1.6m | Unchanged |
| ACUTA CAPITAL PARTNERS, LLC 0.86% of their portfolio | 645.1k $1.5m | Added +445.1k |
| CITIGROUP INC 0.00% of their portfolio | 312.4k $744.0k | Added +79.3k |
| Logos Global Management LP 0.10% of their portfolio | 220.4k $525.0k | Reduced -66.2k |
| BlackRock Inc. 0.00% of their portfolio | 205.3k $489.0k | Reduced -315.6k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 142.8k $340.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 136.9k $325.0k | Added +133.7k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 109.8k $261.0k | Reduced -84.7k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 75.4k $179.0k | New |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 70.3k $167.0k | New |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 42.3k $101.0k | New |
| Ergoteles LLC 0.00% of their portfolio | 36.4k $87.0k | New |
| STATE STREET CORP 0.00% of their portfolio | 31.0k $74.0k | Reduced -113.8k |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 25.0k $60.0k | Reduced -5.8k |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 23.8k $57.0k | New |
| NORTHERN TRUST CORP 0.00% of their portfolio | 17.7k $42.0k | Reduced -70.6k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 15.7k $37.0k | Reduced -4.5k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 14.5k $34.0k | New |
| TUDOR INVESTMENT CORP ET AL 0.00% of their portfolio | 13.6k $32.0k | Unchanged |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 12.9k $31.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 3.1k $7.0k | Added +437 |
| FMR LLC 0.00% of their portfolio | 858 $2.0k | Added +729 |
| Legal & General Group Plc 0.00% of their portfolio | 833 $2.0k | Reduced -142 |
| UBS Group AG 0.00% of their portfolio | 367 $1.0k | Reduced -1.1k |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 108 $0 | Reduced -6.3k |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 70 $0 | Reduced -5.2k |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |